Trial intelligence / Profile preview

Vitamin D Levels and Musculoskeletal Side Effects in Isotretinoin-Treated Acne

NCT04204304Completed

Sponsor
Ankara Training and Research Hospital
Start
Mar 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by Ankara Training and Research Hospital. Primary endpoints: Musculoskeletal adverse effects in isotretinoin receiving patients at 2 days and Serum 25 hydroxy vitamin D level at 7 days. Started Mar 2019; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT04204304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04204304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call